Cargando…

Safety and effectiveness of new embolization microspheres SCBRM for intermediate-stage hepatocellular carcinoma: A feasibility study

Transarterial chemoembolization (TACE) is, currently, the recommended treatment for hepatocellular carcinoma (HCC). However, long-term chemoembolization triggers the inflammatory response and may lead to postembolization syndrome (PES). Although several types of degradable microspheres have been dev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yi-Sheng, Lin, Xi-Zhang, Chen, Chiung-Yu, Chiu, Yen-Cheng, Kang, Jui-Wen, Tsai, Hung-Wen, Hung, Hui-Yu, Ho, Chi-Ming, Ou, Ming-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112559/ https://www.ncbi.nlm.nih.gov/pubmed/32841586 http://dx.doi.org/10.17305/bjbms.2020.4770

Ejemplares similares

Comparison of the Efficacy of Two Microsphere Embolic Agents for Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients
por: Lee, Shao-Hua, et al.
Publicado: (2020)

Traditional versus Microsphere Embolization for Hepatocellular Carcinoma: An Effectiveness Evaluation Using Data Mining
por: Chang, Pi-Yi, et al.
Publicado: (2021)

Transarterial Chemoembolization Using Gelatin Sponges or Microspheres Plus Lipiodol-Doxorubicin versus Doxorubicin-Loaded Beads for the Treatment of Hepatocellular Carcinoma
por: Liu, Yi-Sheng, et al.
Publicado: (2015)

Treating hepatocellular carcinoma with (90)Y-bearing microspheres: a review
por: Hsieh, Te-Chun, et al.
Publicado: (2016)

Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease
por: Hung, Chung-Lin, et al.
Publicado: (2015)

Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
por: Tsai, Hong-Ming, et al.
Publicado: (2021)

Predict Early Recurrence of Resectable Hepatocellular Carcinoma Using Multi-Dimensional Artificial Intelligence Analysis of Liver Fibrosis
por: Liu, I-Ting, et al.
Publicado: (2021)

Hyaluronic acid-based nano-sized drug carrier-containing Gellan gum microspheres as potential multifunctional embolic agent
por: Hsu, Ming Fang, et al.
Publicado: (2018)

Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma
por: Hsu, Wei-Fan, et al.
Publicado: (2021)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Lin, Ming-Tzer, et al.
Publicado: (2010)

Transarterial Embolization for Hepatocellular Carcinoma: A Comparison between Nonspherical PVA and Microspheres
por: Scaffaro, Leandro Armani, et al.
Publicado: (2015)

Quantitative volumetric computed tomography embolic analysis, the Qanadli score, biomarkers, and clinical prognosis in patients with acute pulmonary embolism
por: Huang, Wei-Ming, et al.
Publicado: (2022)

Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection
por: Chi, Chen-Ta, et al.
Publicado: (2021)

Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma
por: Liao, Wen-Ying, et al.
Publicado: (2020)

Sustained-Release and pH-Adjusted Alginate Microspheres-Encapsulated Doxorubicin Inhibit the Viabilities in Hepatocellular Carcinoma-Derived Cells
por: Pan, Cheng-Tang, et al.
Publicado: (2021)

Embolic Microspheres Observed during Metroplasty
por: Brandão, Pedro, et al.
Publicado: (2022)

Biocompatibility of Bletilla striata Microspheres as a Novel Embolic Agent
por: Luo, ShiHua, et al.
Publicado: (2015)

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Hepatitis B Virus X Protein Upregulates mTOR Signaling through IKKβ to Increase Cell Proliferation and VEGF Production in Hepatocellular Carcinoma
por: Yen, Chia-Jui, et al.
Publicado: (2012)

Trans-arterial embolization of a Yakes type IIb inferior mesenteric arteriovenous malformation: A case report and literature review for angio-architecture analysis
por: Su, Bo-Ying, et al.
Publicado: (2023)

Transcatheter arterial embolization with trisacryl gelatin microspheres (Embosphere(®)) leads to life-threatening tumor lysis syndrome in a rectal carcinoid patient with hepatic metastases
por: Lo, Yuan-Hao, et al.
Publicado: (2012)

Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization
por: Chu, Hai-Jui, et al.
Publicado: (2015)

Laparoscopic Liver Resection Should Be a Standard Procedure for Hepatocellular Carcinoma with Low or Intermediate Difficulty
por: Gau, Ruoh-Yun, et al.
Publicado: (2021)

The Influence of Acute Hyperglycemia in an Animal Model of Lacunar Stroke That Is Induced by Artificial Particle Embolization
por: Tsai, Ming-Jun, et al.
Publicado: (2016)

Assessing efficacy of antiviral therapy for COVID-19 patients: A case study on remdesivir with bayesian synthesis design and multistate analysis
por: Liao, Sih-Han, et al.
Publicado: (2021)

Microspheres embolization of juvenile nasopharyngeal angiofibroma in an adult
por: Parikh, Vevek, et al.
Publicado: (2014)

Use of microspheres in embolization for unruptured renal angiomyolipomas
por: Shimohira, Masashi, et al.
Publicado: (2021)

Chronic Kidney Disease Stage Is a Modulator on the Association between High-Sensitivity C-Reactive Protein and Coronary Vasospastic Angina
por: Hsu, Heng-Jung, et al.
Publicado: (2014)

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis
por: Lin, Chih-Wen, et al.
Publicado: (2020)

New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion
por: Li, Ming-Feng, et al.
Publicado: (2022)

Systemic air embolism causing acute stroke and myocardial infarction after percutaneous transthoracic lung biopsy—a case report
por: Hung, Wei-Heng, et al.
Publicado: (2015)

Neuroinflammation in Low-Level PM2.5-Exposed Rats Illustrated by PET via an Improved Automated Produced [(18)F]FEPPA: A Feasibility Study
por: Cheng, Mei-Fang, et al.
Publicado: (2022)

Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry
por: Wang, Ti-Hao, et al.
Publicado: (2018)

Factors associated with chronic musculoskeletal pain in patients with chronic kidney disease
por: Hsu, Heng-Jung, et al.
Publicado: (2014)

Evaluation of the use of a novel bioabsorbable polymer drug-eluting microsphere for transarterial embolization of hepatocellular neoplasia in dogs
por: Culp, William T. N., et al.
Publicado: (2022)

Editorial: Herbal Medicines in Pain Management
por: Hu, Wen-Long, et al.
Publicado: (2022)

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection
por: Chien, Shih-Chieh, et al.
Publicado: (2022)

CPAP enhances and maintains chronic inflammation in hepatocytes to promote hepatocarcinogenesis
por: Chen, Ruo-Yu, et al.
Publicado: (2021)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
por: Wang, Jing-Houng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2jtmmga1439v62cdvtfhsk5kel